Heterologous prime-boost vaccination with ChAdOx1 nCoV-19 and BNT162b2

Affiliations

• ¹ Institute of Clinical and Molecular Virology, University Hospital Erlangen, Universitätsklinikum Erlangen Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.
• ² University Hospital of Cologne, Faculty of Medicine, Department I of Internal Medicine, Cologne, Germany; University of Cologne, Translational Research, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases, Cologne, Germany.
• ³ Institute of Virology, School of Medicine, Technical University of Munich/Helmholtz Zentrum München, 81675 Munich, Germany.
• ⁴ Institute of Molecular Immunology and Experimental Oncology, School of Medicine, University Hospital rechts der Isar, Technical University of Munich, Munich, Germany.
• ⁵ Mikrobiologisches Institut-Klinische Mikrobiologie, Immunologie und Hygiene, Universitätsklinikum Erlangen Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.
• ⁶ Institute of Molecular Immunology and Experimental Oncology, School of Medicine, University Hospital rechts der Isar, Technical University of Munich, Munich, Germany; DZIF, partner sites Munich and Cologne/Bonn, Germany.
• ⁷ Institute of Virology, School of Medicine, Technical University of Munich/Helmholtz Zentrum München, 81675 Munich, Germany; DZIF, partner sites Munich and Cologne/Bonn, Germany. Electronic address: protzer@tum.de.